Related Experiment Videos
Obstacles to clinical research and new drug development in schizophrenia
1Hillside Hospital, Division of Long Island Jewish Medical Center, Glen Oaks, NY 11004.
Abstract:
Enormous opportunities currently exist to develop and test new treatments for schizophrenia. Treatment research not only holds promise for alleviating the suffering and disability associated with this illness, but also in providing clues to etiology and ultimately prevention. At the same time as there are increasing opportunities for treatment development, there are also increasing challenges and obstacles to the conduct of needed research. A variety of different issues need to be addressed in facilitating appropriate research including treatment settings, reimbursement for costs of care, legal and ethical issues affecting patient participation, stable funding, and the development of clinical investigators. Adequate attention to these problems in strategic planning can help to ensure that emerging opportunities are neither wasted nor delayed.
Insights
New treatments for schizophrenia offer hope for patients and insights into the illness. However, research faces significant challenges in areas like funding and patient participation that must be addressed.
Area of Science:
- Psychiatry and Neuroscience
- Clinical Research
Background:
- Schizophrenia treatment research presents significant opportunities for improving patient outcomes and understanding the disorder's causes.
- Despite these opportunities, conducting essential research is increasingly challenging.
Purpose of the Study:
- To highlight the potential of new schizophrenia treatments.
- To identify and address obstacles hindering crucial research in schizophrenia.
Main Methods:
- Review of current opportunities in schizophrenia treatment development.
- Analysis of challenges impacting clinical research conduct.
Main Results:
- Significant opportunities exist for developing and testing novel schizophrenia treatments.
- Key challenges include treatment settings, reimbursement, legal/ethical issues, funding, and investigator development.
Conclusions:
- Addressing identified obstacles through strategic planning is crucial.
- This will ensure that opportunities for advancing schizophrenia research are effectively utilized and not delayed.